Baber U , et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5:S53–S61.

• PubMed
Baber U , Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012; 5:S53–S61.)| false
• Search Google Scholar
• Export Citation

Fang Y , et al. Early chronic kidney disease–mineral bone disorder stimulates vascular calcification. Kidney Int 2014; 85:142–150.

• PubMed
Fang Y , Early chronic kidney disease–mineral bone disorder stimulates vascular calcification. Kidney Int 2014; 85:142–150.)| false
• Search Google Scholar
• Export Citation

Li X , Giachelli CM . Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens 2007; 16:325–328.

• PubMed
Li X , Giachelli CM . Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens 2007; 16:325–328.)| false
• Search Google Scholar
• Export Citation

Giachelli CM . The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75:890–897.

• PubMed
Giachelli CM . The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75:890–897.)| false
• Search Google Scholar
• Export Citation

Schafer C , et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112:357–366.

• PubMed
Schafer C , The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112:357–366.)| false
• Search Google Scholar
• Export Citation

Suliman ME , et al. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Adv Clin Chem 2008; 46:217–262.

• PubMed
Suliman ME , Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Adv Clin Chem 2008; 46:217–262.)| false
• Search Google Scholar
• Export Citation

Cranenburg EC , et al. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009; 101:359–366.

• PubMed
Cranenburg EC , Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009; 101:359–366.)| false
• Search Google Scholar
• Export Citation

Schurgers LJ , et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010; 5:568–575.

• PubMed
Schurgers LJ , The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 2010; 5:568–575.)| false
• Search Google Scholar
• Export Citation

Schlieper G , et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESKD. J Am Soc Nephrol 2011; 22:387–395.

• PubMed
Schlieper G , Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESKD. J Am Soc Nephrol 2011; 22:387–395.)| false
• Search Google Scholar
• Export Citation

Fusaro M , et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012; 27:2271–2278.

• PubMed
Fusaro M , Vitamin K, vertebral fractures, vascular calcifications, and mortality: Vitamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012; 27:2271–2278.)| false
• Search Google Scholar
• Export Citation

Delanaye P , et al. Dephosphorylated-uncarboxylated matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014; 15:145.

• PubMed
Delanaye P , Dephosphorylated-uncarboxylated matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014; 15:145.)| false
• Search Google Scholar
• Export Citation

Meuwese CL , et al. Associations between thyroid hormones, calcification inhibitor levels and vascular calcification in end-stage renal disease. PLoS One 2015; 10:e0132353.

• PubMed
Meuwese CL , Associations between thyroid hormones, calcification inhibitor levels and vascular calcification in end-stage renal disease. PLoS One 2015; 10:e0132353.)| false
• Search Google Scholar
• Export Citation

Thamratnopkoon S , et al. Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 2017; 135:167–172.

• PubMed
Thamratnopkoon S , Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron 2017; 135:167–172.)| false
• Search Google Scholar
• Export Citation

Westenfeld R , et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012; 59:186–195.

• PubMed
Westenfeld R , Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 2012; 59:186–195.)| false
• Search Google Scholar
• Export Citation

Caluwe R , et al. Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol Dial Transplant 2014; 29:1385–1390.

• PubMed
Caluwe R , Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol Dial Transplant 2014; 29:1385–1390.)| false
• Search Google Scholar
• Export Citation